http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114438015-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afb7c6774714bb80dd4ec038c5b60cb8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2509-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2509-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
filingDate 2022-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54e1e70ba68cc366ed4619b5ad1bb280
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc87f9763a9911bae972dd34d1f61164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7821ec6abd19daea1175a2d3bcebf999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98beae53bb183457bc8552429b5217c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beed7524d59945446299d9a5ba725a79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f78313055c955f20f4e33745c96554d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26f9c5ed211686a08b8b51f2730d7bff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aba31c503a98de4e1b4a16e96d4e88dd
publicationDate 2022-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114438015-A
titleOfInvention A human granulosa cell line derived from ovary and its preparation method and application
abstract The invention discloses a human granulosa cell line derived from ovary and a preparation method and application thereof. The human granulosa cell line is human granulosa cell hGC-YH derived from ovary, which has been deposited in the General Microbiology Center (CGMCC) of the China Microorganism Culture Collection on December 3, 2021, and its deposit number is CGMCC No.45005. The human granulosa cell line described in the present invention has high adherence rate, high uniformity, high survival rate and strong stability, and is suitable for studying the mechanism of oocyte maturation, the pathogenesis of polycystic ovary syndrome, the protection mechanism of female reproductive function, and screening Good experimental material for gonadotropin therapy drugs.
priorityDate 2022-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009138855-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113462637-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID470371
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2492
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID195820
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14309
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588251
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281172

Total number of triples: 36.